Invesaro

Stocks Comparison

Davita vs Progyny: revenue, profit, margins and growth compared

Davita brought in $13.6B of revenue in fiscal 2025, Progyny $1.3B in fiscal 2025. Revenue changed by +6.5% at Davita and +10.4% at Progyny on the year before, so Progyny grew faster. Davita kept 5.5% of its revenue as net profit, Progyny 4.5%. Free cash flow was $1.3B at Davita and $191.8M at Progyny.

Side by side, latest fiscal year

DVAPGNY
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$13.6B$1.3B
Revenue growth+6.5%+10.4%
Net income$746.8M$58.5M
Net margin5.5%4.5%
Free cash flow$1.3B$191.8M
Free cash flow margin9.6%14.9%
Earnings per share (diluted)$9.84$0.65
Cash$676.4M$112.2M
Debt$10.3Bn/a
Price to earnings18.139.1
Market value$11.4B$2B
Dividend yieldn/an/a
Rank by revenue in sector#36 of 523 · Health care#133 of 523 · Health care

Over the years

Revenue
DVA FY2018: $11.4BDVA FY2019: $11.4BDVA FY2020: $11.6BDVA FY2021: $11.6BDVA FY2022: $11.6BDVA FY2023: $12.1BDVA FY2024: $12.8BDVA FY2025: $13.6BPGNY FY2019: $105.4MPGNY FY2019: $229.7MPGNY FY2020: $344.9MPGNY FY2021: $500.6MPGNY FY2022: $786.9MPGNY FY2023: $1.1BPGNY FY2024: $1.2BPGNY FY2025: $1.3BFY18FY19FY20FY21FY22FY23FY24FY25
DVA $13.6BPGNY $1.3B
Net income
DVA FY2018: $159.4MDVA FY2019: $811MDVA FY2020: $773.6MDVA FY2021: $978.5MDVA FY2022: $560.4MDVA FY2023: $691.5MDVA FY2024: $936.3MDVA FY2025: $746.8MPGNY FY2019: $661KPGNY FY2019: -$8.6MPGNY FY2020: $46.5MPGNY FY2021: $65.8MPGNY FY2022: $30.4MPGNY FY2023: $62MPGNY FY2024: $54.3MPGNY FY2025: $58.5MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $746.8MPGNY $58.5M
Net margin
DVA FY2018: 1.4%DVA FY2019: 7.1%DVA FY2020: 6.7%DVA FY2021: 8.4%DVA FY2022: 4.8%DVA FY2023: 5.7%DVA FY2024: 7.3%DVA FY2025: 5.5%PGNY FY2019: 0.6%PGNY FY2019: -3.7%PGNY FY2020: 13.5%PGNY FY2021: 13.1%PGNY FY2022: 3.9%PGNY FY2023: 5.7%PGNY FY2024: 4.7%PGNY FY2025: 4.5%FY18FY19FY20FY21FY22FY23FY24FY25
DVA 5.5%PGNY 4.5%
Revenue growth
DVA FY2019: -0.1%DVA FY2020: +1.4%DVA FY2021: +0.6%DVA FY2022: -0.1%DVA FY2023: +4.6%DVA FY2024: +5.6%DVA FY2025: +6.5%PGNY FY2019: +117.9%PGNY FY2020: +50.1%PGNY FY2021: +45.2%PGNY FY2022: +57.2%PGNY FY2023: +38.3%PGNY FY2024: +7.2%PGNY FY2025: +10.4%FY19FY20FY21FY22FY23FY24FY25
DVA +6.5%PGNY +10.4%
Free cash flow
DVA FY2018: $784.5MDVA FY2019: $1.3BDVA FY2020: $1.3BDVA FY2021: $1.3BDVA FY2022: $961.1MDVA FY2023: $1.5BDVA FY2024: $1.5BDVA FY2025: $1.3BPGNY FY2019: $1.7MPGNY FY2019: -$4.5MPGNY FY2020: $35.2MPGNY FY2021: $23.9MPGNY FY2022: $77.2MPGNY FY2023: $185.2MPGNY FY2024: $173.7MPGNY FY2025: $191.8MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $1.3BPGNY $191.8M

Fiscal years as each company reports them; the two may end in different months.

Questions about Davita and Progyny

Which is bigger by revenue, Davita or Progyny?

Davita is bigger by revenue: $13.6B in fiscal 2025, against $1.3B for Progyny in fiscal 2025.

Which keeps more of its revenue as profit, Davita or Progyny?

Davita had a net margin of 5.5% in fiscal 2025; Progyny had 4.5% in fiscal 2025.

Which grew revenue faster, Davita or Progyny?

In their latest fiscal years revenue changed by +6.5% at Davita and +10.4% at Progyny.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies